Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Astelin Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis.

Trial Profile

Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Astelin Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Azelastine/fluticasone-propionate (Primary) ; Azelastine; Fluticasone propionate
  • Indications Seasonal allergic rhinitis; Tree pollen hypersensitivity
  • Focus Registrational; Therapeutic Use
  • Sponsors Meda Pharmaceuticals
  • Most Recent Events

    • 06 Mar 2017 Results of a post hoc analysis presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 20 May 2015 Pooled analysis (efficacy in patients with concomittant asthma) results presented at the 111th International Conference of the American Thoracic Society.
    • 04 Mar 2014 Results presented at the 70th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top